Hjem › Burkitts lymfom › Wisconsin › Milwaukee
Kliniske studier for Burkitts lymfom i Milwaukee, WI
16 studier for Burkitts lymfom søker deltakere på steder i og rundt Milwaukee (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
RekruttererFase 2
- Children's Hospital of Wisconsin, Milwaukee
Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia
RekruttererFase 3
- Medical College of Wisconsin, Milwaukee
Blinatumomab Consolidation in Real World
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
- Medical College of Wisconsin, Milwaukee
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
RekruttererObservasjonsstudie
- Children's Hospital of Wisconsin, Milwaukee
Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia
RekruttererFase 2
- Medical College of Wisconsin, Milwaukee
- Drexel Town Square Health Center, Oak Creek · 11 mi unna
- Froedtert and MCW Moorland Reserve Health Center, New Berlin · 11 mi unna
- og 1 flere
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
RekruttererFase 2
- Children's Hospital of Wisconsin, Milwaukee
Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
RekruttererFase 3
- Medical College of Wisconsin, Milwaukee
Dose-escalation and Dose-expansion Study of Safety of Azer-cel (PBCAR0191) in Participants With Relapsed/Refractory (r/r) Non-Hodgkin Lymphoma (NHL) and r/r B-cell Acute Lymphoblastic Leukemia (B-ALL)
RekruttererFase 1
- Medical College of Wisconsin, Milwaukee
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
RekruttererFase 2
- Children's Hospital of Wisconsin, Milwaukee
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
RekruttererFase 3
- Children's Hospital of Wisconsin, Milwaukee
AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia
RekruttererFase 1/2
- Research Site, Milwaukee
LV20.19 CAR T-Cells in Combination With Pirtobrutinib for Relapsed, Refractory B-cell Malignancies
RekruttererFase 1
- Froedtert & the Medical College of Wisconsin, Milwaukee
MCW Alpha/Beta T-Cell and B-Cell Depletion With Targeted ATG Dosing
Rekrutterer
- Children's Wisconsin, Milwaukee
Study of SGR-1505 in Mature B-Cell Neoplasms
RekruttererFase 1
- Medical College of Wisconsin, Milwaukee
Long-term Follow-up Study of Patients Receiving CAR-T Cells
RekruttererObservasjonsstudie
- Froedtert Hospital & Medical College of Wisconsin, Milwaukee
Blinatumomab After TCR Alpha Beta/CD19 Depleted HCT
RekruttererFase 2
- Children's Hospital of Wisconsin, Milwaukee
Burkitts lymfom-studier i andre byer
- Houston, TX21 studier
- Philadelphia, PA16 studier
- Chicago, IL15 studier
- Cincinnati, OH13 studier
- New York City, NY13 studier
- Atlanta, GA12 studier
- Aurora, CO11 studier
- Seattle, WA11 studier
- Durham, NC10 studier
- Boston, MA10 studier
- Kansas City, MO10 studier
- Los Angeles, CA10 studier
Andre studier i Milwaukee
- Brystkreft23 studier
- Kreft (alle typer)22 studier
- Ikke-småcellet lungekreft22 studier
- Multipelt myelom21 studier
- Lungekreft21 studier
- Prostatakreft20 studier
- Follikulært lymfom19 studier
- Non-Hodgkins lymfom18 studier
- Pankreaskreft18 studier
- Akut myelogen leukemi17 studier
- Eggstokkreft17 studier
- Diffust stort B-cellelymfom16 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.